Banner Before Header

China’s Sinovac reveals detail of mid-stage trial of COVID-19 vaccine

0 18

JAKARTA/BEIJING: Sinovac Biotech is the China’s launched human trial vaccine. It is told that the patients who are involved in Indonesia for COVID-19 vaccine candidate. However, it is Indonesian state-owned peer Bio Farma. 

The vaccine has resulted safe and made clear the detectable antibody based immune response. It is counted among the few potential vaccines. It has been sent for the late-stage trials for knowing the last scale study. In this way, one can gather the proof for the regulatory approval.

Related Posts
1 of 437

It is informed by the officials that this CoronaVac is already in last stage trial in Brazil; however, it is expected that Bangladesh will also test it.

However, the threat will not be reduced until and unless the vaccine is given to all people, said Joko Widodo, the President of Indonesia. Similarly, he also said that in January, hopefully, we can produce and vaccinate every single person in the country.

Leave A Reply

Your email address will not be published.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More